Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, reported more losses but rising revenue in its second quarter earnings. Cure suffered a net loss of $9.6 million in the second quarter of 2022, up substantially from a net loss of $1.3 million in the same quarter a year ago. That equates to an earnings per share loss of 10 cents for the quarter ended June 30. Revenue increased 31% in the quarter, however, to $1.3 million, with more expected growth to come in the third quarter, the company said in a news release.

https://www.pacbiztimes.com/2022/09/06/revenue-and-losses-both-up-at-cure-pharmaceutical/

#pacbiztimes